Researchers Engineered E. coli for Nitrene Synthesis
The biosynthetic platform enables the production of amino alcohols and diamines using engineered enzymes.
Updated on Sept. 22, 2026 in Life Sciences
Live Poll
Do you believe synthetic biology research will ultimately make essential medicines more affordable?
Researchers have constructed an artificial biosynthetic network within Escherichia coli to facilitate nitrene-transfer reactions. This research-stage process utilizes engineered metabolic pathways to synthesize amino alcohols and diamines from simple carbon and nitrogen sources.
Why it matters
The development demonstrates a method for performing complex chemical transformations using microbial hosts. By integrating enzyme engineering with metabolic pathway design, the approach offers a route to synthesize fine chemicals from inexpensive biological feedstocks.
The system achieves 90% enantiomeric excess in amino alcohols by deploying cytochrome P450 nitrene-transfer catalysts. The reaction relies on N-acetoxyarylamine precursors derived from p-aminobenzoic acid and vinyl arenes synthesized from phenylalanine.
The players
Escherichia coli
A common gram-negative bacterium frequently utilized as a chassis for metabolic engineering and synthetic biology applications.
The details
The platform functions by engineering E. coli to express specific enzymes, including the arylamine oxygenase BezJ and acetyltransferase BezG, to mediate precursor biosynthesis. Cytochrome P450 nitrene-transferases from the BezE family then activate these precursors to perform the chemical transformation. Directed evolution—a method that mimics natural selection in the lab to optimize protein function—was used to improve both product titers and stereoselectivity.
Timeline
September 2026: Research findings were published in Nature Catalysis.
The Tech Race
This research follows a broader trend in the development of cytochrome P450-based biocatalysts for non-natural chemical synthesis. It represents a shift from in vitro enzyme applications to living cell systems capable of complex, multi-step chemical production.
This development is currently limited to research-stage laboratory environments and provides no immediate impact on commercial manufacturing workflows. Future utility will depend on the successful optimization of the biosynthetic pathways for industrial-scale fermentation.
The takeaway
The successful integration of nitrene-transfer catalysts into a bacterial host proves the feasibility of performing complex chemical synthesis via engineered metabolism. Researchers and industry stakeholders should monitor future benchmarks regarding yield improvements and the expansion of the substrate scope for these enzymes.
Further reading
For broader developments in microbial engineering, see our coverage of Life Sciences.
Live Poll
Do you believe synthetic biology research will ultimately make essential medicines more affordable?
